Clinical Trials on Perception in Belgium
Total 2 results
-
Institut PasteurInstitut de l'AuditionNot yet recruitingAuditory PerceptionBelgium, France
-
Cliniques universitaires Saint-Luc- Université...Unknown
Sponsors and Collaborators
- Collèges Régionaux de Médecine Générale- CRMG - 18600 SANCOINS
- Sidney Kimmel Cancer Center at Thomas Jefferson University
- Zhuzhou Qianjin Pharmaceutical Co., Ltd., 801, Zhuzhou, China
- The Danish Physiotherapy Foundation
- IGEA
- Hongguan biological pharmaceutical co.
- Carol Davila University of Medicine and Pharmacy
- Pei-Yuan Lee, MD
- Swim Across America Foundation
- Dr. Vivek Aggarwal
- Società Italiana di Chirurgia Endoscopica e nuove tecnologie (SICE)
- Coalition Internationale Sida
- Sana Rouis
- Acerus Biopharma Inc.
- Shanghai Greenvalley Pharmaceutical Co., Ltd.
- GlaxoSmithKline
- Firstbeat Technologies Ltd.
- farzaneh hojjat
- Metro North Hospital and Health Services
- Atos IT Solutions and Services Iberia
- View Full List
Medical Conditions
- Focal Brain Injury
- Pain During Heal Lancing
- Recurrent Abortion
- Orthostasis
- PILONIDAL SINUS
- Thrombosis Cardiac
- Painful Blind Eye
- Limb Paralysis
- Varicose Veins Pelvic
- ABPA
- COVID-19 Infections
- Stage III Wilms Tumor With Loss of Heterozygosity (LOH) for 1p and 16q
- Hantaan Virus Disease, Puumala Virus
- Urinary Frequency or Urgency Adverse Event
- Acne Scars - Mixed Atrophic and Hypertrophic
- Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas
- SCCOHT
- Lymphoblastic Leukemia, Acute
- Preoperative Screen for Substance Abuse in in Patients Undergoing Emergency Operation
- Lung Cancer, Protection Against
- View Full List
Drug Interventions
- Doxophylline
- Standard treatment
- NDI-034858 study drug
- Citalopram
- Ezabenlimab
- 5-FU
- B=Inhaled Alprazolam 0.5 mg
- ITF2357
- R-metHuLeptin
- Medium dose of BIBT 986 CL, per i.v. infusion
- Insulin (Actrapid)
- Antiretroviral drugs
- AUY922
- Rose Bengal
- 0.9% Sodium Chloride Injection
- [C-11]PiB-PET/MRI
- TOCOSOL(R) Paclitaxel
- Paclitaxel (albumin-bound) combined with Oxaliplatin and S-1
- SPARC1104 modified dose regimen III
- BH002
- View Full List
CROs by country
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Cote d'Ivoire
- Contract Research Organizations in Ecuador
- Contract Research Organizations in Ethiopia
- Contract Research Organizations in Hong Kong
- Contract Research Organizations in Kenya
- Contract Research Organizations in Mozambique
- Contract Research Organizations in Norway
- Contract Research Organizations in Panama
- Contract Research Organizations in Togo
- Contract Research Organizations in Tunisia
- Contract Research Organizations in Vietnam
- Contract Research Organizations in Zimbabwe
- CRO list by country